Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
United States
City of Hope Medical Center, Duarte, California University of Chicago Cancer Research Center, Chicago, Illinois Dana-Farber Cancer Institute, Boston, Massachusetts Hackensack University Medical Center/John Theurer Cancer Center, Hackensack, New Jersey Sarah Cannon Research Institute, Nashville, Tennessee Last updated September 2025